insights_auto
Why is MESO down ၄.၁၀%?
Dive Deeperchevron_right
MESO:NASDAQ
Mesoblast Ltd
၁၄.၅၀ US$
arrow_downward
-၄.၁၀%(-၀.၆၂) 1D
၁၄.၅၀ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: စက် ၂၈, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MESO...
Open
၁၄.၄၈ US$
High
၁၄.၆၂ US$
Low
၁၄.၃၁ US$
Mkt. cap
၁၈၈.၉၄ ဋေ
Avg. vol.
၂.၀၉ သိန်း
Volume
၀.၀၀
52-wk high
၂၁.၄၉ US$
52-wk low
၁၃.၀၅ US$
EPS
-၀.၄၄ US$
Beta
၂.၁၂
Shares outstanding
၁၂.၉၉ ကုဋေ
No. of employees
၁၀၈
Open
၁၄.၄၈ US$
High
၁၄.၆၂ US$
Low
၁၄.၃၁ US$
Mkt. cap
၁၈၈.၉၄ ဋေ
Avg. vol.
၂.၀၉ သိန်း
Volume
၀.၀၀
52-wk high
၂၁.၄၉ US$
52-wk low
၁၃.၀၅ US$
EPS
-၀.၄၄ US$
Beta
၂.၁၂
Shares outstanding
၁၂.၉၉ ကုဋေ
No. of employees
၁၀၈
News stories
From web sources and news partners
The Motley Fool Australia
·
ပြီးခဲ့သည့် ၁ ရက်
Could Mesoblast shares rise over 100% in 12 months?
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၂ လ
MESO Q1 2026 Earnings: EPS Miss and No Revenue as Clinical-Stage Biotech Focuses on Regulatory Milestones
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd